|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
11269495 |
| 005 |
20210625185129.9 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
161130s2016 si ob 000 0 eng d |
| 015 |
|
|
|a GBB9E1113
|2 bnb
|
| 016 |
7 |
|
|a 019336369
|2 Uk
|
| 019 |
|
|
|a 964919698
|a 965129468
|a 966403516
|a 967706943
|a 971088689
|a 981029836
|a 1005793551
|a 1011952751
|a 1048102698
|a 1058390064
|a 1066476052
|a 1086540983
|a 1112552987
|a 1113438136
|a 1116073660
|a 1122816861
|a 1127158443
|a 1136238115
|a 1204057972
|
| 020 |
|
|
|a 9789811022906
|q (electronic bk.)
|
| 020 |
|
|
|a 9811022909
|q (electronic bk.)
|
| 020 |
|
|
|z 9789811022890
|
| 020 |
|
|
|z 9811022895
|
| 024 |
7 |
|
|a 10.1007/978-981-10-2290-6
|2 doi
|
| 035 |
|
|
|a (OCoLC)964586608
|z (OCoLC)964919698
|z (OCoLC)965129468
|z (OCoLC)966403516
|z (OCoLC)967706943
|z (OCoLC)971088689
|z (OCoLC)981029836
|z (OCoLC)1005793551
|z (OCoLC)1011952751
|z (OCoLC)1048102698
|z (OCoLC)1058390064
|z (OCoLC)1066476052
|z (OCoLC)1086540983
|z (OCoLC)1112552987
|z (OCoLC)1113438136
|z (OCoLC)1116073660
|z (OCoLC)1122816861
|z (OCoLC)1127158443
|z (OCoLC)1136238115
|z (OCoLC)1204057972
|
| 035 |
|
9 |
|a (OCLCCM-CC)964586608
|
| 037 |
|
|
|a 972721
|b MIL
|
| 040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d N$T
|d DKU
|d IDEBK
|d EBLCP
|d GW5XE
|d IAV
|d OCLCO
|d UPM
|d STF
|d OCLCO
|d OCLCA
|d MERER
|d OCLCF
|d OCLCO
|d N$T
|d IDB
|d N$T
|d ESU
|d UAB
|d OCLCO
|d VT2
|d OCLCQ
|d OCLCO
|d OCLCQ
|d IOG
|d OCLCO
|d MERUC
|d OCLCO
|d CASUM
|d OTZ
|d IAD
|d JBG
|d ICW
|d OCLCO
|d ILO
|d OCLCO
|d ICN
|d OCLCO
|d OCLCQ
|d OCLCO
|d U3W
|d OCLCO
|d OCLCA
|d REB
|d OCLCO
|d CAUOI
|d KSU
|d AU@
|d OCLCO
|d OCLCQ
|d WYU
|d OCLCO
|d OCLCA
|d AUD
|d OCLCQ
|d OCLCO
|d OH1
|d ERF
|d UKMGB
|d LEATE
|d OCLCQ
|d OCLCA
|d OCLCQ
|d UKAHL
|d AJS
|d OCLCA
|d TXI
|d OCLCO
|d DCT
|
| 049 |
|
|
|a MAIN
|
| 050 |
|
4 |
|a R601
|b .E95 2016
|
| 060 |
|
4 |
|a WB 55.C4
|
| 072 |
|
7 |
|a MX
|2 bicssc
|
| 072 |
|
7 |
|a MED004000
|2 bisacsh
|
| 072 |
|
7 |
|a HEA
|x 012000
|2 bisacsh
|
| 072 |
|
7 |
|a HEA
|x 020000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 004000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 101000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 109000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 029000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 040000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 092000
|2 bisacsh
|
| 245 |
0 |
0 |
|a Evidence-based research methods for Chinese medicine /
|c Siu-Wai Leung, Hao Hu, editors.
|
| 264 |
|
1 |
|a Singapore :
|b Springer,
|c [2016]
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 520 |
|
|
|a This book is a practical guide to the evidence-based medicine (EBM) research methods that are applicable to Chinese medicine (CM). It includes 3 parts: clinical research, healthcare data research and laboratory research. In each chapter, it explains how to acquire, analyze and evaluate a specific kind of CM research result. Authors exemplify the most important methods with successful cases in transforming reliable data into new knowledge of CM. This book emphasizes the requirements for CM researchers to design and conduct CM studies by following the best available principles, standards and guidelines.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 505 |
0 |
|
|a Preface; Acknowledgments; Contents; Contributors; 1 Introduction; Abstract; 1.1 Objectives; 1.2 Clinical Research; 1.2.1 Chapter 2 Methodology for Clinical Studies Investigating Chinese Medicine; 1.2.2 Chapter 3 Effectiveness Assessment of Chinese Medicine in Clinical Research; 1.2.3 Chapter 4 Placebo Controlled Trials in Acupuncture: Problems and Solutions; 1.3 Healthcare Data Acquisition and Analysis; 1.3.1 Chapter 5 Qualitative Interview for Chinese Medicine Research: Challenges and Prospects
|
| 505 |
8 |
|
|a 1.3.2 Chapter 6 A Need for Standard Data Collection Procedures in Studies on Traditional Chinese Medicine1.3.3 Chapter 7 Methods for Assessment of Interrater Reliability for Diagnosis and Intervention in Traditional Chinese Medicine Studies; 1.3.4 Chapter 8 Bioinformatics for Molecular Authentication of Chinese Medicinal Materials; 1.4 Laboratory Research; 1.4.1 Chapter 9 Proteomic Response Fingerprinting (ProReF) for Rapid Identification of Protein Targets for Chinese Medicine; 1.4.2 Chapter 10 Chinese Medicine in Neurological Diseases: Pharmacological Perspective
|
| 505 |
8 |
|
|a 1.4.3 Chapter 11 Effects of Chinese Medicinal Components of Chemokine Receptors: Theory, Results and Methodology1.5 Concluding Remarks; 2 Methodology for Clinical Study Investigating Chinese Medicine; Abstract; 2.1 Introduction to Basic Study Design; 2.1.1 Principles of Clinical Study Design; 2.1.1.1 Control; 2.1.1.2 Equalization; 2.1.1.3 Replication; 2.1.1.4 Blinding; 2.1.1.5 Ethics; 2.1.2 Basic Research Methods for Observational Studies; 2.1.2.1 Case Reports/Case Series Studies; 2.1.2.2 Cross-Sectional Studies; 2.1.2.3 Case-Control Studies; 2.1.2.4 Cohort Studies
|
| 505 |
8 |
|
|a 2.1.3 Basic Research Methods for Intervention Studies2.1.3.1 Randomized Controlled Trials; 2.1.3.2 Nonrandomized Controlled Trials; 2.1.4 Basic Research Methods for Comparative Effectiveness Research; 2.1.5 Basic Research Methods for Systematic Review and Meta-analysis; 2.2 Key Issues in Planning, Implementing, Analyzing, and Reporting a Clinical Study; 2.2.1 Planning; 2.2.1.1 Defining a Research Question; 2.2.1.2 Drafting the Study Protocol; 2.2.1.3 Registering the study; 2.2.2 Implementing; 2.2.2.1 Study Management; 2.2.2.2 Data Management; 2.2.3 Analyzing; 2.2.3.1 Steps of Data Analysis
|
| 505 |
8 |
|
|a 2.2.3.2 Basic Principles of Statistical Analysis2.2.4 Reporting; 2.2.4.1 Early Preparation for Publication; 2.2.4.2 Writing the Manuscript; 2.2.4.3 Publishing the Manuscript; Acknowledgments; References; 3 Effectiveness Assessment of Chinese Medicine in Clinical Research; Abstract; 3.1 Introduction; 3.2 Definition of Clinical Effectiveness of Interventions; 3.3 Factors Influencing Clinical Effectiveness: Risk of Bias and PICOS in Clinical Trials; 3.4 Considering CM Characteristics; 3.4.1 Effectiveness Assessment and Outcome Measurement
|
| 650 |
|
0 |
|a Medicine, Chinese.
|0 http://id.loc.gov/authorities/subjects/sh85083125
|
| 650 |
|
0 |
|a Evidence-based medicine.
|0 http://id.loc.gov/authorities/subjects/sh97007984
|
| 650 |
|
0 |
|a Alternative medicine.
|0 http://id.loc.gov/authorities/subjects/sh85134721
|
| 650 |
|
2 |
|a Medicine, Chinese Traditional.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Holism.
|2 bisacsh
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Reference.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Alternative Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Atlases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Essays.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Family & General Practice.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Holistic Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Osteopathy.
|2 bisacsh
|
| 650 |
|
7 |
|a Alternative medicine.
|2 fast
|0 (OCoLC)fst00806153
|
| 650 |
|
7 |
|a Evidence-based medicine.
|2 fast
|0 (OCoLC)fst00917247
|
| 650 |
|
7 |
|a Internal medicine.
|2 fast
|0 (OCoLC)fst00976610
|
| 650 |
|
7 |
|a Medicine.
|2 fast
|0 (OCoLC)fst01014893
|
| 650 |
|
7 |
|a Medicine, Chinese.
|2 fast
|0 (OCoLC)fst01015214
|
| 650 |
|
7 |
|a Pharmacology.
|2 fast
|0 (OCoLC)fst01060259
|
| 655 |
|
0 |
|a Electronic books.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Leung, Siu-Wai,
|e editor.
|
| 700 |
1 |
|
|a Hu, Hao
|c (Researcher on pharmacoepidemiology),
|e editor.
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Print version:
|z 9811022895
|z 9789811022890
|w (OCoLC)953599034
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a oclccm
|
| 999 |
f |
f |
|i 51f51135-af6b-59a3-b4a9-a659210ac04c
|s 255558c3-3841-545d-a4f0-adcf8aefac1b
|
| 928 |
|
|
|t Library of Congress classification
|a R601 .E95 2016
|l Online
|c UC-FullText
|u https://link.springer.com/10.1007/978-981-10-2290-6
|z Springer Nature
|g ebooks
|i 12542323
|
